[ad_1]
- Panel votes unanimously that Alzheimer’s drug does not offer benefitsSTAT
- The FDA “abandoned its responsibility” by approving the drug Biogen Alzheimer: doctorYahoo finance
- Ohio clinic says it will not administer Alzheimer’s drug to patientsThe New York Times
- US review of drug Biogen Alzheimer could have been better handled – FDA chiefReuters
- Mount Sinai decides not to use controversial Alzheimer’s drugCBS New York
- See full coverage on Google News
[ad_2]
Source link